Defying death: The hepatocyte's survival kit

Clinical Science

Volumn 107, Issue 1, 2004, Pages 13-25

  Schoemaker, Marieke H ^a,b   Moshage, Han ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Apoptosis; Cell death; Hepatocyte; Liver injury; Stellate cell; Survival; Therapeutic intervention

Indexed keywords

3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; ALPHA TOCOPHEROL; BILE ACID; CASPASE INHIBITOR; CONCANAVALIN A; CYTOKINE; FAS ANTIBODY; FLICE INHIBITORY PROTEIN; GLIOTOXIN; GLUTATHIONE; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; MEMBRANE PROTEIN; MITOCHONDRIAL PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR RECEPTOR; NITRIC OXIDE DONOR; O VINYL 1 (PYRROLIDIN 1 YL)DIAZEN 1 IUM 1,2 DIOLATE; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; SUPEROXIDE DISMUTASE; TAURINE DERIVATIVE; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; UNINDEXED DRUG; URSODEOXYCHOLIC ACID;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CELL ACTIVITY; CELL DEATH; CELL SURVIVAL; GENE TARGETING; GENE THERAPY; HUMAN; LIVER CELL; LIVER CIRRHOSIS; LIVER DISEASE; LIVER DYSFUNCTION; LIVER FIBROSIS; LIVER INJURY; LIVER NECROSIS; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL SURVIVAL; GENE THERAPY; HEPATOCYTES; HUMANS; LIVER DISEASES; MITOCHONDRIA, LIVER; SIGNAL TRANSDUCTION;

EID: 3142686648     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20040090     Document Type: Review

References (146)

1. Saunders, S. J., Seggie, J., Kirsch, R. E. and Terblanche, J. (1997) Acute liver failure. In Liver and Biliary Disease, Pathophysiology, Diagnosis and Management (Wright, R., Alberti, K. G. M. M., Karran, S. and Millward-Sadler, G. H., eds.), pp. 569-584, W. B. Saunders Company Ltd, London
2. Ramadori, G. and Armbrust, T. (2001) Cytokines in the liver. Eur. J. Gastroenterol. Hepatol. 13, 777-784
3. Jaeschke, H., Gores, G. J., Cederbaum, A. I., Hinson, J. A., Pessayre, D. and Lemasters, J. J. (2002) Mechanisms of hepatotoxicity. Toxicol. Sci. 65, 166-176
4. Lemasters, J. J. (1999) V. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis. Am. J. Physiol. 276, G1-G6
5. Reed, J. C. (2000) Mechanisms of apoptosis. Am. J. Pathol. 157, 1415-1430
6. Granville, D. J., Carthy, C. M., Hunt, D. W. and McManus, B. M. (1998) Apoptosis: Molecular aspects of cell death and disease. Lab. Invest. 78, 893-913
7. Strand, S., Hofmann, W. J., Grambihler, A. et al. (1998) Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat. Med. 4, 588-593
8. Kasahara, I., Saitoh, K. and Nakamura, K. (2000) Apoptosis in acute hepatic failure: histopathological study of human liver tissue using the tunel method and immunohistochemistry. J. Med. Dent. Sci. 47, 167-175
9. Schoemaker, M. H., Gommans, W. M., Conde de la Rosa, L. et al. (2003) Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-κB activation. J. Hepatol. 39, 153-161
10. Fickert, P., Trauner, M., Fuchsbichler, A., Zollner, G. and Wagner, M. (2003) Inhibition of poly(ADP-ribose) polymerase (PARP) protects mice from cholestatic liver injury. Hepatology 38 (suppl. 1), 576A
11. Gujral, J. and Jaeschke, H. (2003) Apoptosis and oncotic necrosis during acute liver injury after bile duct ligation in mice. Hepatology 38 (suppl. 1), 240A
12. Yoon, J. H. and Gores, G. J. (2002) Death receptor-mediated apoptosis and the liver. J. Hepatol. 37, 400-410
13. Trauner, M., Fickert, P. and Stauber, R. E. (1999) Inflammation-induced cholestasis. J. Gastroenterol. Hepatol. 14, 946-959
14. Bortolami, M., Venturi, C., Giacomelli, L. et al. (2002) Cytokine, infiltrating macrophage and T cell-mediated response to development of primary and secondary human liver cancer. Dig. Liver Dis. 34, 794-801
15. Beyaert, R., van Loo, G., Heyninck, K. and Vandenabeele, P. (2002) Signaling to gene activation and cell death by tumor necrosis factor receptors and Fas. Int. Rev. Cytol. 214, 225-272
16. Harper, N., Hughes, M., MacFarlane, M. and Cohen, G. M. (2003) Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis. J. Biol. Chem. 278, 25534-25541
17. Cryns, V. and Yuan, Y. (1999) Proteases to die for. Genes. Dev. 13, 371
18. Scaffidi, C., Fulda, S., Srinivasan, A. et al. (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17, 1675-1687
19. Bradham, C. A., Qian, T., Streetz, K., Trautwein, C., Brenner, D. A. and Lemasters, J. J. (1998) The mitochondrial permeability transition is required for tumor necrosis factor α-mediated apoptosis and cytochrome c release. Mol. Cell Biol. 18, 6353-6364
20. Sokol, R. J., Straka, M. S., Dahl, R. et al. (2001) Role of oxidant stress in the permeability transition induced in rat hepatic mitochondria by hydrophobic bile acids. Pediatr. Res. 49, 519-531
21. Newmeyer, D. D. and Ferguson-Miller, S. (2003) Mitochondria: releasing power for life and unleashing the machineries of death. Cell (Cambridge, Mass.) 112, 481-490
22. Ricci, J. E., Gottlieb, R. A. and Green, D. R. (2003) Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis. J. Cell Biol. 160, 65-75
23. Van Gurp, M., Festjens, N., van Loo, G., Saelens, X. and Vandenabeele, P. (2003) Mitochondrial intermembrane proteins in cell death. Biochem. Biophys. Res. Commun. 304, 487-497
24. Kurose, I., Higuchi, H., Miura, S. et al. (1997) Oxidative stress-mediated apoptosis of hepatocytes exposed to acute ethanol intoxication. Hepatology 25, 368-378
25. Loguercio, C. and Federico, A. (2003) Oxidative stress in viral and alcoholic hepatitis. Free Radicals Biol. Med. 34, 1-10
26. Jaeschke, H., Knight, T. R. and Bajt, M. L. (2003) The role of oxidant stress and reactive nitrogen species in acetaminophen hepatoxicity. Toxicol. Lett. 144, 279-288
27. Kaplowitz, N. (2000) Mechanisms of liver cell injury. J. Hepatol. 32, 39-47
28. Lemasters, J. J., Nieminen, A. L., Qian, T. et al. (1998) The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta 1366, 177-196
29. Kim, J. S., He, L. and Lemasters, J. J. (2003) Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem. Biophys. Res. Commun. 304, 463-470
30. Fesik, S. W. (2000) Insights into programmed cell death through structural biology. Cell (Cambridge, Mass.) 103, 273-282
31. Reed, J. C., Jurgensmeier, J. M. and Matsuyama, S. (1998) Bcl-2 family proteins and mitochondria. Biochim. Biophys. Acta 1366, 127-137
32. Zhao, Y., Ding, W. X., Qian, T., Watkins, S., Lemasters, J. J. and Yin, X. M. (2003) Bid activates multiple mitochondrial apoptotic mechanisms in primary hepatocytes after death receptor engagement. Gastroenterology 125, 854-867
33. Oltvai, Z. N., Milliman, C. L. and Korsmeyer, S. J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell (Cambridge, Mass.) 74, 609-619
34. Diaz, J. L., Oltersdorf, T., Horne, W. et al. (1997) A common binding site mediates heterodimerization and homodimerization of Bcl-2 family members. J. Biol. Chem. 272, 11350-11355
35. Wei, M. C., Zong, W. X., Cheng, E. H. et al. (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science (Washington, D.C.) 292, 727-730
36. Yin, X. M., Wang, K., Gross, A. et al. (1999) Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature (London) 400, 886-891
37. L prevents this release but not tumor necrosis factor-R1/Fas death. J. Biol. Chem. 274, 1156-1163
38. Li, H., Zhu, H., Xu, C. J. and Yuan, J. (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell (Cambridge, Mass.) 94, 491-501
39. Wolter, K. G., Hsu, Y. T., Smith, C. L., Nechushtan, A., Xi, X. G. and Youle, R. J. (1997) Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139, 1281-1292
40. L. Cell (Cambridge, Mass.) 87, 619-628
41. Kelekar, A. and Thompson, C. B. (1998) Bcl-2-family proteins: the role of the BH3 domain in apoptosis. Trends Cell Biol. 8, 324-330
42. Werner, A. B., de Vries, E., Tait, S. W., Bontjer, I. and Borst, J. (2002) Bcl-2 family member Bfl-1/A1 sequesters truncated bid to inhibit is collaboration with proapoptotic Bak or Bax. J. Biol. Chem. 277, 22781-22788
43. L. J. Biol. Chem. 274, 2225-2233
44. L inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein. J. Biol. Chem. 277, 11345-11351
45. Vander Heiden, M. G. and Thompson, C. B. (1999) Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat. Cell Biol. 1, E209-E216
46. Li, P., Nijhawan, D., Budihardjo, I. et al. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell (Cambridge, Mass.) 91, 479-489
47. Slee, E. A., Adrain, C. and Martin, S. J. (1999) Serial killers: ordering caspase activation events in apoptosis. Cell Death Differ. 6, 1067-1074
48. Degli, E. M., Ferry, G., Masdehors, P., Boutin, J. A., Hickman, J. A. and Dive, C. (2003) Post-translational modification of Bid has differential effects on its susceptibility to cleavage by caspase 8 or caspase 3. J. Biol. Chem. 278, 15749-15757
49. Mancini, M., Machamer, C. E., Roy, S. et al. (2000) Caspase-2 is localized at the Golgi complex and cleaves Golgin-160 during apoptosis. J. Cell Biol. 149, 603-612
50. Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A. and Yuan, J. (2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature (London) 403, 98-103
51. Mancini, M., Nicholson, D. W., Roy, S. et al. (1998) The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling. J. Cell Biol. 140, 1485-1495
52. Constantini, P., Bruey, J. M., Castedo, M. et al. (2002) Pre-processed caspase-9 contained in mitochondria participates in apoptosis. Cell Death Differ. 9, 82-88
53. van Loo, G., Saelens, X., Matthijssens, F., Schotte, P., Beyaert, R., Declercq, W. and Vandenabeele, P. (2002) Caspases are not localized in mitochondria during life or death. Cell Death Differ. 9, 1207-1211
54. Susin, S. A., Lorenzo, H. K., Zamzami, N. et al. (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature (London) 397, 441-446
55. van Loo, G., Schotte, P., van Gurp, M. et al. (2001) Endonuclease G: a mitochondrial protein released in apoptosis and involved in caspase-independent DNA degradation. Cell Death Differ. 8, 1136-1142
56. Adrain, C., Creagh, E. M. and Martin, S. J. (2001) Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2. EMBO J. 20, 6627-6636
57. Yamaguchi, H., Bhalla, K. and Wang, H. G. (2003) Bax plays a pivotal role in thapsigargin-induced apoptosis of human colon cancer HCT116 cells by controlling Smac/Diablo and Omi/HtrA2 release from mitochondria. Cancer Res. 63, 1483-1489
58. Verhagen, A. M., Ekert, P. G., Pakusch, M. et al. (2000) Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell (Cambridge, Mass.) 102, 43-53
59. Du, C., Fang, M., Li, Y., Li, L. and Wang, X. (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell (Cambridge, Mass.) 102, 33-42
60. Verhagen, A. M., Silke, J., Ekert, P. G. et al. (2002) HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J. Biol. Chem. 277, 445-454
61. Okabe, H., Irita, K., Taniguchi, S., Kurosawa, K., Tagawa, K., Yoshitake, J. and Takahashi, S. (1994) Endotoxin causes early changes in glutathione concentrations in rabbit plasma and liver. J. Surg. Res. 57, 416-419
62. Xu, Y., Jones, B. E., Neufeld, D. S. and Czaja, M. J. (1998) Glutathione modulates rat and mouse hepatocyte sensitivity to tumor necrosis factor toxicity. Gastroenterology 115, 1229-1237
63. Trauner, M., Meier, P. J. and Boyer, J. L. (1999) Molecular regulation of hepatocellular transport systems in cholestasis. J. Hepatol. 31, 165-178
64. Bohan, A., Chen, W. S., Denson, L. A., Held, M. A. and Boyer, J. L. (2003) Tumor necrosis factor α-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis. J. Biol. Chem. 278, 36688-36698
65. Fausto, N. (2000) Liver regeneration. J. Hepatol. 32, 19-31
66. Fausto, N. and Campbell, J. S. (2003) The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech. Dev. 120, 117-130
67. Bradham, C. A., Plumpe, J., Manns, M. P., Brenner, D. A. and Trautwein, C. (1998) Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am. J. Physiol. 275, G387-G392
68. Beg, A. A. and Baltimore, D. (1996) An essential role for NF-κB in preventing TNF-α-induced cell death. Science (Washington, D.C.) 274, 782-784
69. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R. and Verma, I. M. (1996) Suppression of TNF-α-induced apoptosis by NF-κ-B. Science (Washington, D.C.) 274, 787-789
70. Sakon, S., Xue, X., Takekawa, M. et al. (2003) NF-κB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J. 22, 3898-3909
71. Bellas, R. E., FitzGerald, M. J., Fausto, N. and Sonenshein, G. E. (1997) Inhibition of NF-κB activity induces apoptosis in murine hepatocytes. Am. J. Pathol. 151, 891-896
72. Jobin, C. and Sartor, R. B. (2000) The IκB/NF-κB system: a key determinant of mucosalinflammation and protection. Am. J. Physiol. Cell Physiol. 278, C451-C462
73. Hayakawa, M., Miyashita, H., Sakamoto, I. et al. (2003) Evidence that reactive oxygen species do not mediate NF-κB activation. EMBO J. 22, 3356-3366
74. Flohe, E., Brigelius-Flohe, R., Saliou, C., Traber, M. G. and Packer, L. (1997) Redox regulation of NF-κB activation. Free Radicals Biol. Med. 22, 1115-1126
75. Rothwarf, D. M. and Karin, M. (1999) The NF-κB activation pathway: a paradigm in information transfer from membrane to nucleus. Sci. STKE, RE1
76. Tanaka, M., Fuentes, M. E., Yamaguchi, K. et al. (1999) Embryonic lethality, liver degeneration, and impaired NF-κ-B activation in IKK-β-deficient mice. Immunity 10, 421-429
77. Zandi, E. and Karin, M. (1999) Bridging the gap: composition, regulation, and physiological function of the Iκ-B kinase complex. Mol. Cell Biol. 19, 4547-4551
78. Ting, A. Y. and Endy, D. (2002) Signal transduction. Decoding NF-κB signaling. Science (Washington, D.C.) 298, 1189-1190
79. Hoffmann, A., Levchenko, A., Scott, M. L. and Baltimore, D. (2002) The IκB-NF-κB signaling module: temporal control and selective gene activation. Science (Washington, D.C.) 298, 1241-1245
80. Vos, T. A., Van Goor, H., Tuyt, E. et al. (1999) Expression of inducible nitric oxide synthase in endotoxemic rat hepatocytes is dependent on the cellular glutathione status. Hepatology 29, 421-426
81. Schoemaker, M. H., Ros, J. E., Homan, M. et al. (2002) Cytokine regulation of pro- and anti-apoptotic genes in rat hepatocytes: NF-κB-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosis. J. Hepatol. 36, 742-750
82. Deveraux, Q. L. and Reed, J. C. (1999) IAP family proteins: suppressors of apoptosis. Genes Dev. 13, 239-252
83. Huang, H., Joazeiro, C. A., Bonfoco, E., Kamada, S., Leverson, J. D. and Hunter, T. (2000) The inhibitor of apoptosis, cIAP 2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7. J. Biol. Chem. 275, 26661-26664
84. Chu, Z. L., McKinsey, T. A., Liu, L., Gentry, J. J., Malim, M. H. and Ballard, D. W. (1997) Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. Proc. Natl. Acad. Sci. U.S.A. 94, 10057-10062
85. Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V. and Baldwin, Jr, A. S. (1998) NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science (Washington, D.C.) 281, 1680-1683
86. Chang, L. and Karin, M. (2001) Mammalian MAP kinase signalling cascades. Nature (London) 410, 37-40
87. Roberts, R. A., James, N. H. and Cosulich, S. C. (2000) The role of protein kinase B and mitogen-activated protein kinase in epidermal growth factor and tumor necrosis factor α-mediated rat hepatocyte survival and apoptosis. Hepatology 31, 420-427
88. Rao, Y. P., Studer, E. J., Stravitz, R. T., Gupta, S., Qiao, L., Dent, P. and Hylemon, P. B. (2002) Activation of the Raf-1/MEK/ERK cascade by bile acids occurs via the epidermal growth factor receptor in primary rat hepatocytes. Hepatology 35, 307-314
89. Treisman, R. (1996) Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8, 205-215
90. Vanden Berghe, W., Plaisance, S., Boone, E. et al. (1998) p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem. 273, 3285-3290
91. Foster, F. M., Traer, C. J., Abraham, S. M. and Fry, M. J. (2003) The phosphoinositide (PI) 3-kinase family. J. Cell Sci. 116, 3037-3040
92. Rameh, L. E. and Cantley, L. C. (1999) The role of phosphoinositide 3-kinase lipid products in cell function. J. Biol. Chem. 274, 8347-8350
93. Datta, S. R., Brunet, A. and Greenberg, M. E. (1999) Cellular survival: a play in three Akts. Genes Dev. 13, 2905-2927
94. Khwaja, A. (1999) Akt is more than just a Bad kinase. Nature (London) 401, 33-34
95. Svegliati-Baroni, L., Ridolfi, F., Schoemaker, M. H. et al. (2002) Bile acids induce survival signals in hepatic stellate cells through a PKC- and ERK-dependent mechanism. Hepatology 36 (suppl. 2), 316A
96. Moore, T. A., Lau, H. Y., Cogen, A. L., Monteleon, C. L. and Standiford, T. J. (2003) Anti-tumor necrosis factor-α therapy during murine Klebsiella pneumoniae bacteremia: increased mortality in the absence of liver injury. Shock 20, 309-315
97. Schoemaker, M. H. and Moshage, H. (2003) Die another day. Beyond the journal. J. Hepatol. 38, 873-875
98. Kennedy, J. A., Lewis, H., Clements, W. D. et al. (1999) Kupffer cell blockade, tumour necrosis factor secretion and survival following endotoxin challenge in experimental biliary obstruction. Br. J. Surg. 86, 1410-1414
99. Melgert, B. N., Olinga, P., Van Der Laan, J. M. et al. (2001) Targeting dexamethasone to Kupffer cells: effects on liver inflammation and fibrosis in rats. Hepatology 34, 719-728
100. Miyoshi, H., Rust, C., Roberts, P. J., Burgart, L. J. and Gores, G. J. (1999) Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology 117, 669-677
101. Miyoshi, H., Rust, C., Guicciardi, M. E. and Gores, G. J. (2001) NF-κB is activated in cholestasis and functions to reduce liver injury. Am. J. Pathol. 158, 967-975
102. Gujral, J. S., Farhood, A., Bajt, M. L. and Jaeschke, H. (2003) Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice. Hepatology 38, 355-363
103. Paumgartner, G. and Beuers, U. (2002) Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 36, 525-531
104. Rodrigues, C. M., Sola, S., Sharpe, J. C., Moura, J. J. and Steer, C. J. (2003) Tauroursodeoxycholic acid prevents bax-induced membrane perturbation and cytochrome c relace in isolated mitochondria. Biochemistry 42, 3070-3080
105. Schoemaker, M. H., Conde de la Rosa, L., Buist-Homan, M. et al. (2004) TUDCA protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology, in the press
106. Sokol, R. J., McKim, J. M., Goff, M. C. et al. (1998) Vitamin E reduces oxidant injury to mitochondria and hepatoxicity of intravenous taurochenodeoxycholic acid in the rat. Gastroenterology 114, 164-174
107. Schauer, R. J., Gerbes, A. L., Vonier, D. et al. (2004) Glutathione protects rat liver against reperfusion injury after prolonged warm ischemia. Ann. Surg. 239, 220-231
108. Hentze, H., Latta, M., Kunstle, G., Lucas, R. and Wendel, A. (2003) Redox control of hepatic cell death. Toxicol. Lett. 139, 111-118
109. Iredale, J. P., Benyon, R. C., Pickering, J. et al. (1998) Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J. Clin. Invest. 102, 538-549
110. Wright, M. C., Issa, R., Smart, D. E. et al. (2001) Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology 121, 685-698
111. Dekel, R., Zvibel, I., Brill, S., Brazovsky, E., Halpern, Z. and Oren, R. (2003) Gliotoxin ameliorates development of fibrosis and cirrhosis in a thioacetamide rat model. Dig. Dis. Sci. 48, 1642-1647
112. Beljaars, L., Weert, B., Geerts, A., Meijer, D. K. and Poelstra, K. (2003) The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue. Biochem. Pharmacol. 66, 1307-1317
113. Schoemaker, M. H., Rots, M. G., Beljaars, L. et al. (2003) Redirection of PDGF-receptor targeted adenovirus from hepatocytes to activated stellate cells. Hepatology 38 (suppl. 2), A143
114. Lang, A., Schoonhoven, R., Tuvia, S., Brenner, D. A. and Rippe, R. A. (2000) Nuclear factor κB in proliferation, activation, and apoptosis in rat hepatic stellate cells. J. Hepatol. 33, 49-58
115. Mignon, A., Guidotti, J. E., Mitchell, C. et al. (1998) Selective repopulation of normal mouse liver by Fas/CD95-resistant hepatocytes. Nat. Med. 4, 1185-1188
116. Kane, D. J., Ord, T., Anton, R. and Bredesen, D. E. (1995) Expression of bcl-2 inhibits necrotic neural cell death. J. Neurosci. Res. 40, 269-275
117. Deveraux, Q. L., Roy, N., Stennicke, H. R. et al. (1998) IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 17, 2215-2223
118. Bajt, M. L., Vonderfecht, S. L. and Jaeschke, H. (2001) Differential protection with inhibitors of caspase-8 and caspase-3 in murine models of tumor necrosis factor and Fas receptor-mediated hepatocellular apoptosis. Toxicol. Appl. Pharmacol. 175, 243-252
119. Streetz, K., Leifeld, L., Grundmann, D. et al. (2000) Tumor necrosis factor α in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology 119, 446-460
120. Okano, H., Shiraki, K., Inoue, H. et al. (2003) Cellular FLICE/caspase-8-inhibitory protein as a principal regulator of cell death and survival in human hepatocellular carcinoma. Lab. Invest. 83, 1033-1043
121. Li, J. and Billiar, T. R. (1999) The anti-apoptotic actions of nitric oxide in hepatocytes. Cell Death Differ. 6, 952-955
122. Tzeng, E., Billiar, T. R., Williams, D. L. et al. (1998) Adenovirus-mediated inducible nitric oxide synthase gene transfer inhibits hepatocyte apoptosis. Surgery 124, 278-283
123. Ou, J., Carlos, T. M., Watkins, S. C. et al. (1997) Differential effects of nonselective nitric oxide synthase (NOS) and selective inducible NOS inhibition on hepatic necrosis, apoptosis, ICAM-1 expression, and neutrophil accumulation during endotoxemia. Nitric Oxide 1, 404-416
124. Saavedra, J. E., Billiar, T. R., Williams, D. L., Kim, Y. M., Watkins, S. C. and Keefer, L. K. (1997) Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-α-induced apoptosis and toxicity in the liver. J. Med. Chem. 40, 1947-1954
125. Liu, J., Li, C., Waalkes, M. P., Clark, J., Myers, P., Saavedra, J. E. and Keefer, L. K. (2003) The nitric oxide donor, V-PYRRO/NO, protects against acetaminophen-induced hepatotoxicity in mice. Hepatology 37, 324-333
126. Harbrecht, B. G. and Billiar, T. R. (1995) The role of nitric oxide in Kupffer cell-hepatocyte interactions. Shock 3, 79-87
127. Wheeler, M. D., Kono, H., Yin, M. et al. (2001) Delivery of the Cu/Zn-superoxide dismutase gene with adenovirus reduces early alcohol-induced liver injury in rats. Gastroenterology 120, 1241-1250
128. Zhong, Z., Froh, M., Wheeler, M. D., Smutney, O., Lehmann, T. G. and Thurman, R. G. (2002) Viral gene delivery of superoxide dismutase attenuates experimental cholestasis-induced liver fibrosis in the rat. Gene Ther. 9, 183-191
129. Song, E., Lee, S. K., Wang, J. et al. (2003) RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9, 347-351
130. Zender, L., Hütker, S., Liedtke, C. et al. (2003) Caspase-8 small interfering RNA prevents acute liver failure in mice. Proc. Natl. Acad. Sci. U.S.A. 100, 7797-7802
131. Zender, L. and Kubicka, S. (2004) SiRNA based strategies for inhibition of aoptotic pathways in vivo: analytical and therapeutic implications. Apoptosis 9, 51-54
132. Xue, F., Takahara, T., Yata, Y. et al. (2003) Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy. Gut 52, 694-700
133. Hwang, T. H., Yoon, B. C., Jeong, J. S., Seo, S. Y. and Lee, H. Y. (2003) A single administration of adenoviral-mediated HGF cDNA permits survival of mice from acute hepatic failure. Life Sci. 72, 851-861
134. Schulze-Bergkamen, H., Brenner, D., Krueger, A. et al. (2004) Hepatocyte growth factor induces mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt. Hepatology 39, 645-654
135. Ferran, C., Stroka, D. M., Badrichani, A. Z. et al. (1998) A20 inhibits NF-κB activation in endothelial cells without sensitizing to TNF-mediated apoptosis. Blood 91, 2249-2258
136. Daniel, S., Arvelo, M. B. and Ferran, C. (2001) Overexpression of A20 in endothelial cells of vascularized Grafts creates a protective barrier against TNF and FAS-mediated apoptosis. Transpl. Proc. 33, 225
137. Arvelo, M. B., Cooper, J. T., Longo, C. et al. (2002) A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis. Hepatology 35, 535-543
138. Zheng, T. S., Hunot, S., Kuida, K. et al. (2000) Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation. Nat. Med. 6, 1241-1247
139. Cauwels, A., Janssen, B., Waeytens, A., Cuvelier, C. and Brouckaert, P. (2003) Caspase inhibition causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phospholipase A2. Nat. Immunol. 4, 387-393
140. Khwaja, A. and Tatton, L. (1999) Resistance to the cytotoxic effects of tumor necrosis factor α can be overcome by inhibition of a FADD/caspase-dependent signaling pathway. J. Biol. Chem. 274, 36817-36823
141. Schmitt, C. A. and Lowe, S. W. (1999) Apoptosis and therapy. J. Pathol. 187, 127-137
142. Shiraki, K., Sugimoto, K., Yamanaka, Y. et al. (2003) Overexpression of X-linked inhibitor of apoptosis in human hepatocellular carcinoma. Int. J. Mol. Med. 12, 705-708
143. Takahashi, M., Saito, H., Atsukawa, K., Ebinuma, H., Okuyama, T. and Ishii, H. (2003) Bcl-2 prevents doxorubicin-induced apoptosis of human liver cancer cells. Hepatol. Res. 25, 192-201
144. Chiu, C. T., Yeh, T. S., Hsu, J. C. and Chen, M. F. (2003) Expression of Bcl-2 family modulated through p53-dependent pathway in human hepatocellular carcinoma. Dig. Dis. Sci. 48, 670-676
145. D'Sa-Eipper, C., Subramanian, T. and Chinnadurai, G. (1996) Bfl-1, a bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity. Cancer Res. 56, 3879-3882
146. Roy, H. K., Olusola, B. F., Clemens, D. L. et al. (2002) AKT proto-oncogene overexpression is an early event during sporadic colon carcinogensis. Carcinogenesis 23, 201-205